Stuck Anna K, Spirk David, Schaudt Jil, Kucher Nils
Nils Kucher, MD, Division of Vascular Medicine, Swiss Cardiovascular Center, University Hospital Bern, 3010 Bern, Switzerland, Tel.: +41 31 632 21 11, Fax: +41 31 632 04 28, E-mail:
Thromb Haemost. 2017 Apr 3;117(4):801-808. doi: 10.1160/TH16-08-0631. Epub 2017 Feb 2.
Although the use of thromboprophylaxis is recommended for acutely ill medical patients at increased risk of venous thromboembolism (VTE), it remains unclear which risk assessment model (RAM) should be routinely used to identify at-risk patients requiring thromboprophylaxis. We therefore aimed to describe existing RAMs, and to compare these tools in terms of validity and applicability for clinical decision-making. We performed a comprehensive systematic search in MEDLINE from the date of initiation until May 2016 for studies in acutely ill medical patients investigating validity of RAMs for VTE. Two reviewers independently screened the title, abstract, and full text, and evaluated the characteristics of studies, and the composition, evidence of validation, and results on validity of the RAMs. We included 11 studies assessing eight RAMs: 4-Element RAM, Caprini RAM, a full logistic model, Geneva risk score, IMPROVE-RAM, Kucher Model, a "Multivariable Model", and Padua Prediction Score. The 4-Element RAM, IMPROVE-RAM, Multivariable Model, and full logistic model had derivation by identifying factors with predictive power. The other four RAMs were empirically generated based on consensus guidelines, published data, and clinical expertise. The Kucher Model, the Padua Prediction Score, the Geneva Risk Score and the IMPROVE-RAM underwent multicenter external validation. The Kucher Model, the Padua Prediction Score, and the Geneva Risk Score improved rates of thromboprophylaxis or clinical outcomes. In conclusion, existing RAMs to evaluate the need of thromboprophylaxis in acutely ill medical patients are difficult to compare and none fulfills the criteria of an ideal RAM. Nevertheless, the adequacy of thromboprophylaxis may be improved by implementing one of the validated RAMs.
尽管对于静脉血栓栓塞症(VTE)风险增加的急性病内科患者推荐使用血栓预防措施,但目前仍不清楚应常规使用哪种风险评估模型(RAM)来识别需要进行血栓预防的高危患者。因此,我们旨在描述现有的RAM,并在有效性和临床决策适用性方面比较这些工具。我们在MEDLINE中进行了全面的系统检索,检索时间从起始日期至2016年5月,以查找有关急性病内科患者中调查RAM对VTE有效性的研究。两名审阅者独立筛选标题、摘要和全文,并评估研究的特征以及RAM的组成、验证证据和有效性结果。我们纳入了11项评估8种RAM的研究:四要素RAM、卡普里尼RAM、完整逻辑模型、日内瓦风险评分、IMPROVE-RAM、库彻模型、“多变量模型”和帕多瓦预测评分。四要素RAM、IMPROVE-RAM、多变量模型和完整逻辑模型通过识别具有预测能力的因素进行推导。其他四种RAM是根据共识指南、已发表数据和临床专业知识凭经验生成的。库彻模型、帕多瓦预测评分、日内瓦风险评分和IMPROVE-RAM进行了多中心外部验证。库彻模型、帕多瓦预测评分和日内瓦风险评分提高了血栓预防率或临床结局。总之,现有的用于评估急性病内科患者血栓预防需求的RAM难以比较,且没有一个符合理想RAM的标准。然而,实施其中一种经过验证的RAM可能会提高血栓预防的充分性。